Ancillary Study to Protocol 20060104

Amgen

Status: Completed

Conditions: Rheumatoid Arthritis

Treatments: Procedure: Blood draw

Study type: Observational

Funder types: Industry

Identifiers

NCT00439894

20060364

Details and patient eligibility

About

Ancillary study to the Etanercept protocol 20060104. Subjects have been asked to provide additional blood samples for further assessment.

Enrollment: 50 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Signed informed Consent Meet all inclusion critieria outlined in Amgen Protocol 20060104

Exclusion criteria

• Meet exclusion criteria outlined in Amgen Protocol 20060104

Trial design

50 participants in 1 patient group

blood draw

Description:

One time blood draw

Treatment:

Procedure: Blood draw